search icon

    Market Snapshot

    • S&P Futures

      3,809.5

    • Dow Futures

      30,868

    • Nasdaq Futures

      11,633.25

    blog search icon

    Galera Therapeutics, Inc.

    (NASDAQ:GRTX)

    $1.3

    $-0.02

    -1.52%

    Galera Therapeutics, Inc. Chart

    GRTX Stock Price Today

    Galera Therapeutics, Inc. (GRTX) stock declined over -1.52% intraday to trade at $1.30 a share on NASDAQ. The stock opened with a loss of -12.16% at $1.4 and touched an intraday high of $1.39, falling -1.52% against the last close of $1.32. The stock went to a low of $1.26 during the session.

    Stock Snapshot

    $1.32

    Prev. Close

    31.47 Million

    Market Cap

    $1.26

    Day Low

    $1.4

    Open

    26.75 Million

    Number of Shares

    $1.39

    Day High

    -

    P/E ratio

    -2.95

    EPS (TTM)

    2.66

    Cash Flow per Share

    2.34

    Free Float in %

    -1.63

    Book Value

    84,929

    Volume

    Galera Therapeutics, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-30$1.4$1.39$1.26$1.384,889
    2022-06-29$1.48$1.5$1.27$1.32266,800
    2022-06-28$1.5$1.57$1.476$1.5468,300
    2022-06-27$1.5$1.53$1.36$1.52119,600
    2022-06-24$1.33$1.47$1.29$1.4580,700
    2022-06-23$1.29$1.42$1.29$1.3142,800
    2022-06-22$1.27$1.34$1.27$1.2836,700
    2022-06-21$1.39$1.43$1.26$1.27244,200
    2022-06-17$1.38$1.45$1.33$1.3871,000
    2022-06-16$1.44$1.45$1.36$1.3925,600

    Contact Details

    2 West Liberty Boulevard
    Suite 100
    Malvern, PA 19355
    United States

    Webiste:GRTX

    610 725 1500

    Company Information

    Employees-

    Beta-

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

    Frequently Asked Questions

    icon

    What is the current Galera Therapeutics, Inc. (GRTX) stock price?

    Galera Therapeutics, Inc. (NASDAQ: GRTX) stock price is $1.3 as of the last check on Thursday, June 30. During the trading session, GRTX stock reached the peak price of $1.39 while $1.26 was the lowest point it dropped to.

    icon

    GRTX's industry and sector of operation?

    The NASDAQ listed GRTX is part of Biotechnology industry that operates in the broader Health Care sector. Galera Therapeutics, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer.

    icon

    Who are the executives of GRTX?

    Mr. Christopher Degnan
    CFO & Sec.
    Mr. Joel F. Sussman
    Chief Accounting Officer & Treasurer
    Dr. Dennis P. Riley Ph.D.
    Chief Scientific Officer
    Mr. Arthur J. Fratamico
    Chief Bus. Officer

    icon

    What is the GRTX stock price today?

    GRTX stock traded closed the last session at $1.3, which is $-0.02 or -1.52% lower than its previous close of $1.32. GRTX's current trading price is 13.04% lower than its 52-week high of $10.79 where as its distance from 52-week low of 1.15% is -87.95%.

    icon

    How many employees does GRTX have?

    Number of GRTX employees currently stands at -. GRTX operates from 2 West Liberty Boulevard, Suite 100, Malvern, PA 19355, United States.

    icon

    Link for GRTX official website?

    Official Webiste of $GRTX is: https://www.galeratx.com

    icon

    How do I contact GRTX?

    GRTX could be contacted at GRTX operates from 2 West Liberty Boulevard, Suite 100, Malvern, PA 19355, United States, or at phone #610 725 1500 and can also be accessed through its website.

    icon

    How many shares of GRTX are traded daily?

    GRTX stock volume for the day was 84,929 shares while in the previous session number of GRTX shares traded was 84,889 . The average number of GRTX shares traded daily for last 3 months was 144.81 Thousands.

    icon

    How much did GRTX change today?

    The percentage change in GRTX stock occurred in the recent session was -1.52% while the dollar amount for the price change in GRTX stock was $-0.02.

    icon

    What price range GRTX stock been trading in?

    In the recent session, the day high for GRTX stock was $1.39 while the low for GRTX stock touched on the day was $1.26.

    icon

    What is the market cap of GRTX currently?

    The market value of GRTX currently stands at 31.47 Million with its latest stock price at $1.3 and 26.75 Million of its shares outstanding.